HAPP - Happiness Biotech Group Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.4000
+0.1600 (+3.77%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.2400
Open4.2400
Bid4.4100 x 900
Ask4.4500 x 1000
Day's Range4.0800 - 4.4500
52 Week Range3.9100 - 5.2400
Volume35,170
Avg. Volume43,754
Market Cap110M
Beta (5Y Monthly)N/A
PE Ratio (TTM)5.41
EPS (TTM)0.8140
Earnings DateJan 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.50
  • PR Newswire

    Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019

    Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2019. The financial results has been filed in a 6-K with the U.S. Securities and Exchange Commission (the "SEC") on January 10, 2020.

  • PR Newswire

    Happiness Biotech Announces the Opening of its First Experience Store in Hainan, China, introducing the Company's 31st Experience Store

    Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today the opening of its first experience store in Hainan, China, which is the Company's 31st experience store.

  • GlobeNewswire

    Univest Securities, LLC. Announces Closing of IPO for its Client Happiness Biotech Group Limited (NASDAQ: HAPP), Marking the Second Nasdaq IPO of Uinvest in 2019

    Univest Securities, LLC, a FINRA and SIPC member full-service investment bank and securities broker-dealer firm, today announced the closing of previously announced the initial public offering (“IPO”) for its client Happiness Biotech Group Limited (“Happiness” or Nasdaq: HAPP), marking the second Nasdaq IPO underwritten as the lead-left underwriter and the sole book-runner by Uinvest in 2019. On a firm commitment basis, Univest sold, on behalf of Happiness, 2,000,000 shares of its ordinary shares at of $5.50 per share for a total of $11,000,000 in gross proceeds before fees and expenses.

  • PR Newswire

    Happiness Biotech Group Limited Announces Closing of US$11 Million Firm Commitment Initial Public Offering

    NANPING, China, Oct. 30, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today the closing of previously announced a U.S. underwritten initial public offering ("Offering") of 2,000,000 ordinary shares at a price to the public of $5.50 per share. The Company received aggregate gross proceeds of $11 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts.

  • GlobeNewswire

    Univest Securities, LLC. Announces Trading of IPO for its Client Happiness Biotech Group Limited (NASDAQ: HAPP), Marking the Second Nasdaq IPO and Listing Deal of Uinvest in 2019

    Univest Securities, LLC, a FINRA and SIPIC member full-service investment bank and securities broker-dealer firm, today announced the pricing and trading of the initial public offering (“IPO”) for its client Happiness Biotech Group Limited (“Happiness”), marking the second Nasdaq IPO underwritten byUinvest in 2019. On a firm commitment basis, Univest sold, on behalf of Happiness, 2,000,000 shares of its ordinary shares at of $5.50 per share for a total of $11,000,000 in gross proceeds before fees and expenses.

  • PR Newswire

    Happiness Biotech Group Limited Announces Pricing of US$11 Million Firm Commitment Initial Public Offering

    NANPING, China, Oct. 25, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company"), an innovative China-based nutraceutical and dietary supplements producer, announced today the pricing of a U.S. underwritten initial public offering ("Offering") of 2,000,000 ordinary shares at a price to the public of $5.50 per share. The Company expects to receive aggregate gross proceeds of $11 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts.